Bausch Health pays down $100 million more senior secured term loans

By Wendy Van Sickle

Columbus, Ohio, Jan. 29 – Bausch Health Cos. Inc. paid down another $100 million of its senior secured term loans, the company announced in a press release on Tuesday.

The paydown was funded using cash from operations.

On Dec. 19, Bausch Health announced it had paid down $76 million of the secured term loans.

“As Bausch Health pivots to offense in 2019, we continue to remain committed to reducing our overall debt using cash flow generated from operations,” Joseph C. Papa, chairman and chief executive officer of Bausch Health, said in Tuesday’s release.

Bausch Health is a Laval, Quebec-based specialty pharmaceutical company. The company was formerly known as Valeant Pharmaceuticals International, Inc.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.